Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Fig 1.

Study design overview.

Abbreviations: HD, hemodialysis; VAS[Pi, Sj], VAS score of Period i in Sequence j (i = 0, I, W, II; j = EL, LE); SF-36[Pi, Sj], SF-36 score of Period i in Sequence j (i = 0, I, W, II; j = EL, LE); W, Wash-out. Arrows indicate VAS score measurements. The arrowhead indicates the SF-36 measurement. Squares with dotted lines indicate non-hemodialysis days and squares with solid lines indicate hemodialysis days.

More »

Fig 1 Expand

Table 1.

The amount of VAS and SF-36 improvement before and after intervention by each sequence.

More »

Table 1 Expand

Fig 2.

Study flow diagram.

All study subjects completed the study and were included in the statistical analysis of outcomes.

More »

Fig 2 Expand

Table 2.

Baseline characteristics of patients.

More »

Table 2 Expand

Table 3.

Comparison of improvement in visual analog scale (VAS) score between EMLA and lidocaine tape.

More »

Table 3 Expand

Table 4.

Comparison of changes in SF-36 scores from baseline between sequences.

More »

Table 4 Expand